Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
01/1993
01/19/1993US5180824 Preparation of 2-fluoroadenine, fludarabine or fuldarabine phosphate
01/19/1993US5180714 Adenosine compounds for the treatment of diseases caused by parasitic protozoa
01/13/1993EP0521941A1 Cmp-activated fluorescent sialinic acids and process for producing them
01/13/1993EP0275249B1 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments
01/12/1993US5179200 Nucleosides
01/12/1993US5179087 Antibody inhibitors
01/12/1993US5179084 Antiviral phosphoric acid esters of oxetanocins
01/12/1993CA1312599C 2',3'dideoxy-2',2'difluoronucleosides
01/07/1993WO1993000444A1 Biotinylated photoaffinity nucleotide analogues - synthesis and application
01/07/1993EP0418309A4 Oligonucleotide analogs containing sulfur
01/06/1993CN1067654A Processes for diastereoselective synthesis of nucleosides
01/05/1993US5177196 Used for diagnostic and chemotherapeutic purposes
01/05/1993US5177064 Targeted drug delivery via phosphonate derivatives
01/05/1993US5177063 Avermectin compounds with a 6,5-spiroketal ring system
12/1992
12/30/1992EP0520557A1 A process for the glycosylation of avermectin compounds
12/30/1992EP0520552A1 Derivatives of (hetero) aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them
12/29/1992US5175291 Reaction of 1,4-dioxaspiro 4,4!nonan-7-carboxylic acid with carbonyldiimidazole with 5,6-diamino-1,3-dipropyluracil in the presence of calcium hydroxide and hydroxylating
12/29/1992US5175274 Therapeutic nucleosides
12/29/1992US5175273 Pyridinone or pyrimidinone nucleoside bases containing fused aromatic polycyclic rings
12/29/1992US5175267 Reacting with a silyl halide to form a silyl enol ether, reaction with a selenenyl halide and reduction to furanose and condensing with a heterocyclic base
12/29/1992US5175266 Oxidizing hydroxymethyl function of azidodeoxynucleosides to acid in presence of ruthenium tetroxide
12/27/1992CA2071574A1 Process for the glycosylation of avermectin compounds
12/23/1992WO1992022662A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992WO1992022661A1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
12/23/1992WO1992022565A1 Modified sialyl lewisx compounds
12/23/1992WO1992022564A1 Immunosuppressive and tolerogenic modified lewisx and lewisa compounds
12/23/1992WO1992022563A1 Modified sialyl lewisa compounds
12/23/1992WO1992022548A1 PROCESS FOR PRODUCING 2',3'-DIDEOXY-β-NUCLEOSIDE
12/23/1992WO1992022301A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/23/1992EP0519731A1 4a-Substituted avermectin derivatives
12/23/1992EP0519464A1 Nucleoside derivatives and production thereof
12/23/1992CN1067245A Processes for diastereoselective synthesis of nucleosides
12/23/1992CA2110997A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992CA2110707A1 Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds
12/23/1992CA2110495A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/22/1992WO1993000351A1 Novel anti-viral compounds and processes for production of anti-viral compounds
12/22/1992CA2158009A1 Anti-viral compounds and processes for production of anti-viral compounds
12/22/1992CA2071690A1 Derivatives of (hetero) aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them
12/21/1992CA2071803A1 4a-substituted avermectin derivatives
12/17/1992DE4119075A1 New nucleoside tri:phosphoric acid ester derivs. - used for prepn. of polymerase chain reaction probes, amplification of nucleic acid sequences and as chain terminators for sequences
12/16/1992EP0517796A1 Oligonucleotide analogs.
12/16/1992CN1019495B Preparation for pyrimidine derivative
12/15/1992US5171849 2' and 3' Carboranyl uridines and their diethyl ether adducts
12/15/1992CA1311428C Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups, fluorescent dyes, and other detectable moieties
12/10/1992WO1992021692A1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action
12/10/1992WO1992021688A1 New perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
12/10/1992WO1992021343A1 Novel pyrazinone n-oxide nucleosides and analogs thereof
12/10/1992WO1992021337A1 Methods of treating injury to the central nervous system
12/10/1992WO1992004359A3 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
12/09/1992EP0517573A1 Pharmaceutical compositions for the treatment of airway disorders
12/09/1992EP0517262A1 Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
12/09/1992EP0516851A1 Physiologically active substance well capable of permeating biomembrane
12/08/1992WO1992021689A1 Silyl phosphorylating reagents and methods of using them
12/08/1992US5169956 Macrolide antibiotic compounds
12/08/1992US5169851 Administering for fungal infections in mammals
12/08/1992US5169839 Pesticides for animals and plants
12/08/1992US5169778 Culture which produces insecticidal enzyme inhibitor for glucohydrolases
12/08/1992CA2107911A1 Silyl phosphorylating reagents and methods of using them
12/08/1992CA1311201C Desazapurine-nucleoside derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof fornucleic acid sequencing and as antiviral agents
12/06/1992WO1992021690A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same
12/06/1992CA2088787A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same
12/02/1992EP0516186A2 Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
12/02/1992EP0515514A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
12/02/1992CN1019302B Polycyclic ether antibioties
12/01/1992WO1992021352A1 USE OF 1-(β-D-ARABINOFURANOSYL)-5-PROPYNYLURACIL FOR LOWERING SERUM CHOLESTEROL
12/01/1992CA2088264A1 Nucleoside derivative
11/1992
11/26/1992WO1992020823A1 Backbone modified oligonucleotide analogs
11/26/1992WO1992020822A1 Backbone modified oligonucleotide analogues
11/26/1992WO1992020816A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/26/1992WO1992020696A1 Processes for the diastereoselective synthesis of nucleosides
11/26/1992WO1992020669A1 Processes for the diastereoselective synthesis of nucleosides
11/26/1992WO1992020646A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them
11/26/1992WO1992020347A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
11/26/1992WO1992020336A2 Novel cholesterol lowering compounds
11/26/1992DE4117186A1 Oligo-2'-desoxynukleotide und ihre verwendung als arzneimittel mit antiviraler wirksamkeit Oligo-2'-deoxynucleotides and their use as medicaments having antiviral efficacy
11/26/1992CA2109523A1 Novel cholesterol lowering compounds
11/26/1992CA2103378A1 Backbone modified oligonucleotide analogues
11/26/1992CA2103050A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/25/1992EP0515157A1 Processes for the diastereoselective synthesis of nucleosides
11/25/1992EP0515156A1 Processes for the diastereo-selective synthesis of nucleosides
11/25/1992EP0514568A1 Antiprotozoal compositions containing 2-nitroimidazole derivatives
11/25/1992EP0514513A1 Method and means for oligonucleotide synthesis.
11/25/1992EP0248084B1 Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives
11/24/1992US5166330 Process for the preparation of nucleoside alkyl-aralkyl- and aryl-phosphonites and -phosphonates
11/24/1992US5166328 Antiischemic agents and nervous system disorders
11/24/1992US5166327 Acetylation of 3'-deoxy-3'-fluoro-5'-mesylthymidine and deacetylation
11/24/1992US5166141 Antigen specific immunune response by contacting lymphocytes
11/24/1992US5165231 Anti-reversion exhaust system
11/23/1992WO1992020346A1 Method and composition to reduce myocardial reperfusion injury
11/22/1992CA2103464A1 Backbone modified oligonucleotide analogs
11/19/1992EP0514090A1 Procedure for the inversion of the stereochemistry at C13 of avermectin aglycone compounds
11/19/1992EP0514036A2 Preparation of thionucleosides
11/19/1992EP0513200A1 Method and compositions for the synthesis of bch-189 and related compounds
11/19/1992EP0513067A1 A pratical synthesis of 2'-deoxynucleosides and 2',3'-dideoxy-2',3'-didehydronucleosides
11/17/1992US5164500 Viricides
11/17/1992US5164491 High efficiency
11/17/1992CA2087158A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/14/1992CA2068388A1 Procedure for the inversion of the sterochemistry at c13 of avermectin aglycone compounds
11/12/1992WO1992019637A1 Oligonucleotide analogs containing thioformacetal linkages
11/12/1992WO1992019278A1 Use of macrolide compounds for eye diseases